Combined oral contraceptives
Sponsors
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Omar Mamdouh Shaaban, University of Southern California, Women and Infants Hospital of Rhode Island, Cairo University
Conditions
Abnormal Uterine BleedingAbnormal Uterine Bleeding, Endometrial Hemostatic DysfunctionAbnormal Uterine Bleeding, Ovulatory DysfunctionAdenomyosisChlamydia InfectionHypothalamic-pituitary-ovarian Axis, Gonadotropins, Ethinyl Estradiol, Contraceptive EfficacyNeisseriaceae InfectionPremenstrual Syndrome
Phase 2
Phase 3
Combined Oral Contraceptives and Fluoxetine Versus Combined Oral Contraceptives in Severe Premenstrual Syndrome
NCT02488538
Start: 2015-07-31Target: 300Updated: 2017-01-23
Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome?
NCT02562053
Start: 2015-10-31End: 2017-09-30Target: 300Updated: 2016-07-06
Hormone Replacement for Premature Ovarian Insufficiency
WithdrawnNCT02922348
Start: 2016-03-01End: 2018-12-01Updated: 2019-07-05
Unknown Phase
Hormonal Contraception and Risk of Chlamydia and Gonorrhea
TerminatedNCT00091728
Start: 1997-09-30End: 2001-08-31Target: 1200Updated: 2005-11-07
Oral Contraceptive Hormone-free Interval Pituitary/ Ovarian Activity
CompletedNCT01953211
Updated: 2019-07-26
Stopping Heavy Periods Project
NCT02002260
Start: 2013-02-28End: 2021-12-31Target: 59Updated: 2021-08-02
A randomized controlled trial of two different regimen in the treatment of unfavourable vaginjal bleeding in women on etonogestrel implant
Active, not recruitingPACTR202508557960619
Start: 2025-11-01Target: 70Updated: 2026-01-27